Nanosponge-Encapsulated Polyoxometalates: Unveiling the Multi-Faceted Potential Against Cancers and Metastases Through Comprehensive Preparation, Characterization, and Computational Exploration
<b>Background/Objectives</b>: This study examined the fabrication and characterization of nanosponges (NS) laden with polyoxometalates (TiW<sub>11</sub>Co) with the intention of targeting malignancy. <b>Methods</b>: By employing the emulsion solvent diffusion technique, TiW<sub>11</sub>Co-NS were generated by combining polyvinyl alcohol (PVA) and ethyl cellulose (EC) in different concentrations. <b>Results</b>: A significant numerical results encompassed a hydrodynamic particle diameter of 109.5 nm, loading efficiencies reaching 85.9%, and zeta potentials varying from -24.91 to -27.08 (mV). Scanning and transmission electron microscopy were employed to validate the TiW<sub>11</sub>Co-NS porous structure and surface morphology. The results of the stability investigation indicated that TiW<sub>11</sub>Co-NS exhibited prolonged sturdiness. Investigation examining the inhibition of enzymes revealed that TiW<sub>11</sub>Co-NS exhibited enhanced effectiveness against TNAP. Pharmacological evaluations of TiW<sub>11</sub>Co-NS demonstrated improved cytotoxicity and apoptotic effects in comparison to pure TiW<sub>11</sub>Co, thereby indicating their potential utility in targeted cancer therapy. In vivo investigations involving mice revealed that TiW<sub>11</sub>Co-NS caused a more substantial reduction in tumor weight and increased survival rates in comparison to pure TiW<sub>11</sub>Co. The resemblance of TiW<sub>11</sub>Co for crucial proteins associated with cancer proliferation was featured through molecular docking, thereby supporting its therapeutic potential. <b>Conclusions</b>: The TiW<sub>11</sub>Co-laden nanosponges demonstrated superior stability, enzyme inhibition, cytotoxicity, and in vivo anticancer efficacy, underscoring their potential for targeted cancer therapy.
Authors
- Hamid Saeed Shah (ORCID: https://orcid.org/0000-0003-4396-5235)
- Muhammad Sajjad (ORCID: https://orcid.org/0000-0002-1036-2510)
- Seema Zargar (ORCID: https://orcid.org/0000-0002-5622-0841)
- Muhammad Zubair Malik (ORCID: https://orcid.org/0000-0001-5574-2288)
- Tahir Ali Chohan (ORCID: https://orcid.org/0000-0003-1755-9671)
- Muhammad Sarfraz (ORCID: https://orcid.org/0000-0002-0516-4966)
- Faisal Usman (ORCID: https://orcid.org/0000-0002-8998-9454)
- Tanveer A. Wani
- A. Awan (ORCID: https://orcid.org/0000-0002-8726-2921)
- Zobia Jawad
Institutions
- Bahauddin Zakariya University (PK)
- King Edward Medical University (PK)
- University of Sargodha (PK)
- Al Ain University (AE)
- King Saud University (SA)
- Queen's Hospital (GB)
- University of Veterinary and Animal Sciences (PK)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3390/ph18030347
- Citations
- 2
- Primary Topic
- Advanced Nanomaterials in Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 1.04